Actively Recruiting

Phase Not Applicable
Age: 22Years +
All Genders
ID07354139

Examining Speech Production Errors in Stuttering Using High Definition Transcranial Direct Current Stimulation

Led by The University of Texas at Dallas · Updated on 2026-04-14

50

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether a type of noninvasive brain stimulation called High Definition Transcranial Direct Current Stimulation (HD-tDCS) can reduce speech errors like repetitions, blocks, and prolongations in adults who stutter. This pilot study aims to help design future treatments by targeting specific brain areas involved in speech production and motor planning. Participants' speech and behavior will be assessed during speaking and non-speaking tasks before and after the stimulation to understand its effects on speech fluency. Participants will complete an online survey about 24 hours before a clinic visit that lasts about three hours. During the visit, they will first undergo a stuttering evaluation and complete speaking and non-speaking tasks. Then, they will receive a 20-minute session of HD-tDCS, where low electrical currents are applied through electrodes placed on a special cap targeting either the left inferior frontal gyrus (Broca's area) or the presupplementary motor area of the brain. After stimulation, participants will repeat the initial evaluations and tasks. Throughout the study, all sessions will be audio-recorded. Researchers will measure stuttering severity and how well participants perform naming and button-push tasks before and after stimulation. Safety will be monitored, including any dizziness during stimulation. Participants may rinse residual gel from their scalp after the session. Total participation involves the online survey plus the single clinic visit. The study is randomized and single-blinded, aiming to understand how targeted brain stimulation may influence speech production in people who stutter.

CONDITIONS

Brief Title

Using Non-invasive Brain Stimulation to Explore Potential Treatments to Reduce Speech Errors in Adults Who Stutter

Who Can Participate

Age: 22Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be 22 years old or older
  • May be bi/multilingual but must speak English as dominant language
  • Must be diagnosed or suspected of developmental stuttering disorder
  • Must be able to attend the session at the clinic location
Not Eligible

You will not qualify if you...

  • Patients with other speech or neurological disorders affecting speech (e.g., apraxia, cerebral palsy, Tourette's)
  • Acquired or neurogenic stuttering
  • History of seizures
  • Unexplained episodes of loss of consciousness
  • Unstable or uncontrolled neuropsychiatric illness
  • Implanted brain medical devices or pacemakers
  • Electrically, magnetically, or mechanically activated implants
  • Cardiac, neural, or medication implants
  • Vascular clips or electrically sensitive brain supports
  • Serious brain injury
  • Skin damage at stimulation sites
  • Skin problems like dermatitis, psoriasis, or eczema
  • Severe or frequent headaches
  • Serious life-threatening diseases (e.g., heart failure, chronic lung disease, active cancer)
  • Pregnant women
  • Alcohol or controlled substance use within 24 hours of appointment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Implementation

Duration - 1 day

Participants receive a single 20-minute session of non-invasive brain stimulation targeting either the speech production area or the motor planning region of the brain to explore potential treatments to reduce speech errors.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Callier Clinical Research Center

Richardson, Texas, United States, 75080

Actively Recruiting

Loading map...

Research Team

C

Christine H Abasi, MS-SLP

J

John Hart Jr., MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here